Published in Heart Vessels on May 29, 2010
Cost-effectiveness of chronic kidney disease mass screening test in Japan. Clin Exp Nephrol (2011) 0.97
Relationship between cardio-ankle vascular index (CAVI) and coronary artery calcification (CAC) in patients with type 2 diabetes mellitus. Heart Vessels (2011) 0.86
Metabolic syndrome and renal injury. Cardiol Res Pract (2011) 0.79
Uncontrolled home blood pressure in the morning is associated with nephropathy in Japanese type 2 diabetes. Heart Vessels (2011) 0.76
Efficacy analysis of the renoprotective effects of aliskiren in hypertensive patients with chronic kidney disease. Heart Vessels (2012) 0.76
Effect of blood pressure lowering and antihypertensive drug class on progression of hypertensive kidney disease: results from the AASK trial. JAMA (2002) 12.29
The effects of dietary protein restriction and blood-pressure control on the progression of chronic renal disease. Modification of Diet in Renal Disease Study Group. N Engl J Med (1994) 11.65
Efficacy and safety of benazepril for advanced chronic renal insufficiency. N Engl J Med (2006) 6.25
Angiotensin-receptor blockade versus converting-enzyme inhibition in type 2 diabetes and nephropathy. N Engl J Med (2004) 6.21
Use of single voided urine samples to estimate quantitative proteinuria. N Engl J Med (1983) 3.32
Modification of the Modification of Diet in Renal Disease (MDRD) Study equation for Japan. Am J Kidney Dis (2007) 2.74
Antiproteinuric effect of the calcium channel blocker cilnidipine added to renin-angiotensin inhibition in hypertensive patients with chronic renal disease. Kidney Int (2007) 2.61
Predicting renal outcome in IgA nephropathy. J Am Soc Nephrol (1997) 2.12
Urinary protein excretion rate is the best independent predictor of ESRF in non-diabetic proteinuric chronic nephropathies. "Gruppo Italiano di Studi Epidemiologici in Nefrologia" (GISEN). Kidney Int (1998) 1.99
Plasminogen activator inhibitor-1 in chronic kidney disease: evidence and mechanisms of action. J Am Soc Nephrol (2006) 1.82
Bradykinin decreases plasminogen activator inhibitor-1 expression and facilitates matrix degradation in the renal tubulointerstitium under angiotensin-converting enzyme blockade. J Am Soc Nephrol (2004) 1.61
Proteinuria patterns and their association with subsequent end-stage renal disease in IgA nephropathy. Nephrol Dial Transplant (2002) 1.52
A five-year comparison of the renal protective effects of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in patients with non-diabetic nephropathy. Intern Med (2006) 1.41
Renal angiotensin type 2 receptors mediate natriuresis via angiotensin III in the angiotensin II type 1 receptor-blocked rat. Hypertension (2005) 1.30
Effects of combined ACE inhibitor and angiotensin II antagonist treatment in human chronic nephropathies. Kidney Int (2003) 1.21
Differential bonding interactions of inverse agonists of angiotensin II type 1 receptor in stabilizing the inactive state. Mol Endocrinol (2007) 1.12
The effect of angiotensin-converting-enzyme inhibitors on progression of advanced polycystic kidney disease. Kidney Int (2005) 1.02
Chronic progression of tubulointerstitial damage in proteinuric renal disease is mediated by complement activation: a therapeutic role for complement inhibitors? J Am Soc Nephrol (2003) 0.97
ACE inhibitor reduces growth factor receptor expression and signaling but also albuminuria through B2-kinin glomerular receptor activation in diabetic rats. Am J Physiol Renal Physiol (2007) 0.94
Angiotensin II and its metabolites stimulate PAI-1 protein release from human adipocytes in primary culture. Hypertension (2001) 0.93
Progression rate to end-stage renal failure in non-diabetic kidney diseases: a multivariate analysis of determinant factors. Nephrol Dial Transplant (1995) 0.92
Effects of combination therapy with enalapril and losartan on the rate of progression of renal injury in rats with 5/6 renal mass ablation. J Am Soc Nephrol (1998) 0.88
Gene expression profiling in the remnant kidney model of wild type and kinin B1 and B2 receptor knockout mice. Kidney Int (2007) 0.88
Angiotensin IV stimulates plasminogen activator inhibitor-1 expression in proximal tubular epithelial cells. Kidney Int (1999) 0.87
The role of renin-angiotensin-aldosterone system inhibition in chronic kidney disease. Expert Rev Cardiovasc Ther (2003) 0.85
Additive antiproteinuric effect of combined ACE inhibition and angiotensin II receptor blockade. J Hypertens (2002) 0.83
Efonidipine reduces proteinuria and plasma aldosterone in patients with chronic glomerulonephritis. Hypertens Res (2007) 0.83
Inpatients with coronary heart disease have a high prevalence of chronic kidney disease based on estimated glomerular filtration rate (eGFR) in China. Heart Vessels (2007) 0.82
Kinins are involved in the antiproteinuric effect of angiotensin-converting enzyme inhibition in experimental diabetic nephropathy. Int Immunopharmacol (2003) 0.81
Angiotensin-converting enzyme inhibition and angiotensin II antagonism in nondiabetic chronic nephropathies. Semin Nephrol (2004) 0.81
Clinical prognostic factors in biopsy-proven benign nephrosclerosis. Nephrol Dial Transplant (2003) 0.79
L-158,809 and (D-Ala(7))-angiotensin I/II (1-7) decrease PAI-1 release from human umbilical vein endothelial cells. Thromb Res (2002) 0.79
Bradykinin as a major endogenous regulator of endothelial function. Pediatr Pathol Mol Med (2002) 0.78
The antiproteinuric action of angiotensin-converting enzyme is dependent on kinin. J Am Soc Nephrol (1995) 0.77
Theoretical basis and clinical evidence for differential effects of angiotensin-converting enzyme inhibitors and angiotensin II receptor subtype 1 blockers. Curr Opin Nephrol Hypertens (2000) 0.76
Prognostic factors for a composite end-point of renal outcomes in patients with chronic kidney disease. Ther Apher Dial (2006) 0.75
Effects of candesartan cilexetil (TCV-116) and enalapril in 5/6 nephrectomized rats. Kidney Int Suppl (1997) 0.75
Calcium channel blockers and renal protection: insights from the latest clinical trials. J Am Soc Nephrol (2005) 0.75
Role of kinins in the renoprotective effect of angiotensin-converting enzyme inhibitors in experimental chronic renal failure. Kidney Blood Press Res (1998) 0.75
Will angiotensin II receptor antagonists be renoprotective in humans? Kidney Int (1996) 0.75
[Increased expression of plasminogen activator inhibitor-1 in hypoxic renal injury and its pathological significance in progression of advanced renal disease]. Rinsho Byori (2005) 0.75
Revised equations for estimated GFR from serum creatinine in Japan. Am J Kidney Dis (2009) 18.60
Modification of the Modification of Diet in Renal Disease (MDRD) Study equation for Japan. Am J Kidney Dis (2007) 2.74
Prevalence of chronic kidney disease (CKD) in the Japanese general population predicted by the MDRD equation modified by a Japanese coefficient. Clin Exp Nephrol (2007) 2.58
Estimation of glomerular filtration rate by the MDRD study equation modified for Japanese patients with chronic kidney disease. Clin Exp Nephrol (2007) 2.20
Klotho reduces apoptosis in experimental ischaemic acute kidney injury via HSP-70. Nephrol Dial Transplant (2009) 1.75
The importance of low blood urea nitrogen levels in pregnant patients undergoing hemodialysis to optimize birth weight and gestational age. Kidney Int (2009) 1.64
Switching from allopurinol to febuxostat for the treatment of hyperuricemia and renal function in patients with chronic kidney disease. Clin Rheumatol (2014) 1.50
Urinary free light chain is a potential biomarker for ISN/RPS class III/IV lupus nephritis. Rheumatology (Oxford) (2013) 1.46
A nationwide survey of rapidly progressive glomerulonephritis in Japan: etiology, prognosis and treatment diversity. Clin Exp Nephrol (2009) 1.44
IgG4-related tubulointerstitial nephritis and lymphadenopathy after therapy for malignant lymphoma. Intern Med (2012) 1.42
Pretreatment with 5-FU enhances cisplatin cytotoxicity in head and neck squamous cell carcinoma cells. Cancer Chemother Pharmacol (2007) 1.41
P53 mutation correlates with cisplatin sensitivity in head and neck squamous cell carcinoma lines. Head Neck (2003) 1.40
Chronic Kidney Disease Japan Cohort study: baseline characteristics and factors associated with causative diseases and renal function. Clin Exp Nephrol (2010) 1.39
Chronic Kidney Disease Japan Cohort (CKD-JAC) study: design and methods. Hypertens Res (2008) 1.39
Histologic criteria for diagnosing encapsulating peritoneal sclerosis in continuous ambulatory peritoneal dialysis patients. Adv Perit Dial (2003) 1.29
ANCA-associated systemic vasculitis in Japan: clinical features and prognostic changes. Clin Exp Nephrol (2012) 1.27
Potential roles of large mafs in cell lineages and developing pancreas. Pancreas (2006) 1.27
Left ventricular hypertrophy is associated with arterial stiffness and vascular calcification in hemodialysis patients. Hypertens Res (2004) 1.24
Immunolocalization of WNK4 in mouse kidney. Histochem Cell Biol (2011) 1.17
Reduced Klotho expression level in kidney aggravates renal interstitial fibrosis. Am J Physiol Renal Physiol (2012) 1.16
Chronic kidney disease in long-term survivors of myeloablative allogeneic haematopoietic cell transplantation: prevalence and risk factors. Nephrol Dial Transplant (2009) 1.13
Pathogenesis and treatment of autosomal-dominant nephrogenic diabetes insipidus caused by an aquaporin 2 mutation. Proc Natl Acad Sci U S A (2006) 1.09
Clinical correlates of ambulatory BP monitoring among patients with CKD. Clin J Am Soc Nephrol (2013) 1.03
Epigenetic inactivation of galanin receptor 1 in head and neck cancer. Clin Cancer Res (2008) 1.02
Tissue-preserving approach to extracting DNA from paraffin-embedded specimens using tissue microarray technology. Head Neck (2007) 1.01
Histological heterogeneity of glomerular segmental lesions in focal segmental glomerulosclerosis. Int Urol Nephrol (2011) 1.01
Progression of aortic arch calcification and all-cause and cardiovascular mortality in chronic hemodialysis patients. Int Urol Nephrol (2009) 1.01
Management of anemia in chronic kidney disease patients: baseline findings from Chronic Kidney Disease Japan Cohort Study. Clin Exp Nephrol (2011) 0.99
Severity of nephrotic IgA nephropathy according to the Oxford classification. Int Urol Nephrol (2012) 0.99
ATF3 protects against renal ischemia-reperfusion injury. J Am Soc Nephrol (2008) 0.99
Successful use of single-dose rituximab for the maintenance of remission in a patient with steroid-resistant nephrotic syndrome. Intern Med (2009) 0.99
Japanese Society for Dialysis Therapy guidelines for management of cardiovascular diseases in patients on chronic hemodialysis. Ther Apher Dial (2012) 0.99
Association of single-nucleotide polymorphisms in the polymeric immunoglobulin receptor gene with immunoglobulin A nephropathy (IgAN) in Japanese patients. J Hum Genet (2003) 0.98
Association between single-nucleotide polymorphisms in selectin genes and immunoglobulin A nephropathy. Am J Hum Genet (2002) 0.98
Characteristics of dialysis-related amyloidosis in patients on haemodialysis therapy for more than 30 years. Nephrol Dial Transplant (2008) 0.98
Effects of sevelamer on the progression of vascular calcification in patients on chronic haemodialysis. Nephron Clin Pract (2008) 0.98
How to manage HIV-infected patients with chronic kidney disease in the HAART era. Clin Exp Nephrol (2012) 0.97
Aortic arch calcification and arterial stiffness are independent factors for diastolic left ventricular dysfunction in chronic hemodialysis patients. Circ J (2008) 0.96
Sentinel lymph node radiolocalization in clinically negative neck oral cancer. Head Neck (2006) 0.96
Effect of single-dose rituximab on steroid-dependent minimal-change nephrotic syndrome in adults. Nephrol Dial Transplant (2012) 0.96
Neutral solution low in glucose degradation products is associated with less peritoneal fibrosis and vascular sclerosis in patients receiving peritoneal dialysis. Perit Dial Int (2012) 0.95
Kidney tubular damage in the absence of glomerular defects in HIV-infected patients on highly active antiretroviral therapy. Nephrol Dial Transplant (2011) 0.95
Overweight and obesity accelerate the progression of IgA nephropathy: prognostic utility of a combination of BMI and histopathological parameters. Clin Exp Nephrol (2012) 0.95
Galanin receptor 1 has anti-proliferative effects in oral squamous cell carcinoma. J Biol Chem (2005) 0.94
Urinary albumin excretion within the normal range is an independent risk for near-term development of kidney disease in HIV-infected patients. Nephrol Dial Transplant (2011) 0.93
Characteristics of patients on hemodialysis therapy for more than 30 years. Ther Apher Dial (2007) 0.92
Risk factors for progression in patients with early-stage chronic kidney disease in the Japanese population. Intern Med (2008) 0.92
Simple evaluation of aortic arch calcification by chest radiography in hemodialysis patients. Hemodial Int (2009) 0.91
The characteristics of relapse in adult-onset minimal-change nephrotic syndrome. Clin Exp Nephrol (2007) 0.91
Single-nucleotide polymorphisms in the class II region of the major histocompatibility complex in Japanese patients with immunoglobulin A nephropathy. J Hum Genet (2002) 0.91
Elevated E/E' predicts cardiovascular events in hemodialysis patients with preserved systolic function. Intern Med (2012) 0.90
Different effects of L/N-type and L-type calcium channel blockers on the renin-angiotensin-aldosterone system in SHR/Izm. Am J Nephrol (2009) 0.90
Role of cytosolic NADP+-dependent isocitrate dehydrogenase in ischemia-reperfusion injury in mouse kidney. Am J Physiol Renal Physiol (2008) 0.90
C4d Immunohistochemistry in glomerulonephritis with different antibodies. Clin Exp Nephrol (2007) 0.90
Neutrophil gelatinase-associated lipocalin is a sensitive biomarker for the early diagnosis of acute rejection after living-donor kidney transplantation. Int Urol Nephrol (2012) 0.89
Loss of chromosome arm 18q with tumor progression in head and neck squamous cancer. Genes Chromosomes Cancer (2004) 0.89
Aortic arch calcification evaluated on chest X-ray is a strong independent predictor of cardiovascular events in chronic hemodialysis patients. Heart Vessels (2011) 0.89
Comparison between steroid pulse therapy alone and in combination with tonsillectomy for IgA nephropathy. Int Urol Nephrol (2012) 0.88
Assessment of coronary artery calcification in hemodialysis patients using multi-detector spiral CT scan. Hypertens Res (2004) 0.88
Evaluation of optimal drug concentration in histoculture drug response assay in association with clinical efficacy for head and neck cancer. Oral Oncol (2006) 0.88
Role of mitogen-activated protein kinase in the regulation of transforming growth factor-beta-induced fibronectin accumulation in cultured renal interstitial fibroblasts. Clin Exp Nephrol (2004) 0.88
The significance of caveolae in the glomeruli in glomerular disease. J Clin Pathol (2011) 0.88
Circulating levels of soluble α-Klotho in patients with chronic kidney disease. Clin Exp Nephrol (2011) 0.88
Clinical characteristics of kidney disease in Japanese HIV-infected patients. Nephron Clin Pract (2011) 0.87
Impact of the Fukushima Daiichi Nuclear Power Plant accident on hemodialysis facilities: an evaluation of radioactive contaminants in water used for hemodialysis. Ther Apher Dial (2012) 0.87
Relationship of high-molecular-weight adiponectin levels to visceral fat accumulation in hemodialysis patients. Intern Med (2010) 0.87
Beneficial effect of aliskiren combined with olmesartan in reducing urinary protein excretion in patients with chronic kidney disease. Int Urol Nephrol (2011) 0.87
A case of Mikulicz's disease complicated with severe interstitial nephritis associated with IgG4. Clin Exp Nephrol (2009) 0.87
Aortic arch calcification and clinical outcome in patients with end-stage renal disease. Tohoku J Exp Med (2011) 0.86
Comparison of serum albumin, serum C-reactive protein, and pulse wave velocity as predictors of the 4-year mortality of chronic hemodialysis patients. J Atheroscler Thromb (2011) 0.86
Clinical effects of calcium channel blockers and renin-angiotensin-aldosterone system inhibitors on changes in the estimated glomerular filtration rate in patients with polycystic kidney disease. Clin Exp Nephrol (2010) 0.86
Combined cyclosporine and prednisolone therapy in adult patients with the first relapse of minimal-change nephrotic syndrome. Nephrol Dial Transplant (2009) 0.86
Autosomal dominant polycystic kidney disease: recent advances in pathogenesis and potential therapies. Clin Exp Nephrol (2012) 0.86
Risk factors for vitamin D deficiency in patients with chronic kidney disease. Intern Med (2012) 0.86
Clinical assessment of tacrolimus therapy in lupus nephritis: one-year follow-up study in a single center. Nephron Clin Pract (2009) 0.86
Effect of single-dose rituximab on primary glomerular diseases. Nephron Clin Pract (2010) 0.86
Fatal diffuse pulmonary arterial thrombosis as a complication of nephrotic syndrome. Clin Exp Nephrol (2007) 0.86
Effect of sensory inputs on the soleus H-reflex amplitude during robotic passive stepping in humans. Exp Brain Res (2010) 0.86
Patterns in the prevalence of hepatitis C virus infection at the start of hemodialysis in Japan. Clin Exp Nephrol (2008) 0.85
Aortic arch calcification predicts cardiovascular and all-cause mortality in maintenance hemodialysis patients. Kidney Blood Press Res (2014) 0.85
The effectiveness of steroid therapy for patients with advanced IgA nephropathy and impaired renal function. Clin Exp Nephrol (2004) 0.85
Eicosapentaenoic acid restores diabetic tubular injury through regulating oxidative stress and mitochondrial apoptosis. Am J Physiol Renal Physiol (2010) 0.85
[A case of immunotactoid glomerulopathy with IgA2, kappa deposition ameliorated by steroid therapy]. Nihon Jinzo Gakkai Shi (2003) 0.85
Long-term beneficial effects of angiotensin-converting enzyme inhibitor and angiotensin receptor blocker therapy for patients with advanced immunoglobulin A nephropathy and impaired renal function. Clin Exp Nephrol (2011) 0.84
In situ expression of connective tissue growth factor in human crescentic glomerulonephritis. Virchows Arch (2004) 0.84
Associations between vascular calcification, arterial stiffness and bone mineral density in chronic hemodialysis patients. Geriatr Gerontol Int (2009) 0.84
Mast cells and tubulointerstitial fibrosis in patients with ANCA-associated glomerulonephritis. Clin Exp Nephrol (2003) 0.84
Plasma levels of fibroblast growth factor-23 and mineral metabolism in diabetic and non-diabetic patients on chronic hemodialysis. Int Urol Nephrol (2008) 0.84
Frequency of renal disease in Japan: an analysis of 2,404 renal biopsies at a single center. Nephron Clin Pract (2010) 0.84